Cambrex has researched the many changes that the market has seen in that time to evaluate whether history can be used to anticipate future needs.
Assisted by some of the leading industry figures who had been both witness to and participants in the evolution of (what we now call) the contract manufacturing sector, the history can be broken down into four distinct chapters.
These periods can be reviewed with hindsight to predict the challenges and potential direction of the fifth and future stage of the active pharmaceutical ingredient (API) industry.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.